Advertisement
Screener

Carisma Therapeutics Inc. Temporary Equity, Accretion to Redemption Value

Carisma Therapeutics Inc. Temporary Equity, Accretion to Redemption Value

Carisma Therapeutics Inc. reported Temporary Equity, Accretion to Redemption Value of -$163.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2016-03-25.

Discontinued › Shareholders' Equity

us-gaap:TemporaryEquityAccretionToRedemptionValue · last filed 2016-03-25

  • Carisma Therapeutics Inc. temporary equity, accretion to redemption value for fiscal 2013 was -$163.00K.
Period endTemporary Equity, Accretion to Redemption Value 12 month
2013-12-31-$163.00K
10-K · filed 2016-03-25